Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gene Therapy
Research results from Memorial Sloan Kettering Cancer Center update understanding of gene therapy
December 2nd, 2008
A report, 'Stem cell engineering for the treatment of severe Hemoglobino-pathies,' is newly published data in Current Molecular Medicine. According to recent research published in the journal Current Molecular Medicine, "The beta-thalassemias and sickle cell anemia are severe congenital anemias for which there is presently no curative therapy other than allogeneic bone marrow transplantation. This therapeutic option, however, is not available to most patients due to the lack of an HLA-matched bone marrow donor." "Emerging modalities based on cell engineering offer new prospects for potentially curative approaches that are applicable to more patients. The...
Source: Cancer Weekly (2008-12-02)
|
